Polymorphs and salts of 6-(1h-indol-4-yl)-4-(5- {[4-(1-methylethyl)-1-PI perazinyl] methyl} -1,3-oxazol-2-yl)-1h-indazole as PIK inhibitors for use in the treatment of e.g. respiratory disorders

• 收藏
• 分享

专利权人:

Glaxo Group Limited

发明人:

Hamblin, Julie Nicole,Jones, Paul Spencer,Keeling, Suzanne Elaine,Le, Joelle,Parr, Nigel James,Willacy, Robert David

申请号：

AU2011322649

公开号：

AU2011322649A1

申请日:

2011.10.25

申请国别(地区):

AU

年份:

2013

代理人:

摘要：

The present invention is directed to a polymorph of a compound of formula (II) and salts and polymorphs thereof, which is an inhibitor of PI3 kinase activity.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/